Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial

RESULTS: There were a total of 60 patients who were followed up. Three patients in Group II were removed from the analysis as they underwent total knee arthroplasty (TKA). A notably significant improvement was noticed in the ABMDC group on all scores of VAS and MKSSSF with P < 0.0001. The control...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadat-Ali, Mir, AlOmran, Abdallah S., AlMousa, Sulaiman A., AlSayed, Hasan N., AlTabash, Khalid W., Azam, Mohammed Q., Hegazi, Tarek M., Acharya, Sadananda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627347/
https://www.ncbi.nlm.nih.gov/pubmed/34845428
http://dx.doi.org/10.1155/2021/2146722
Descripción
Sumario:RESULTS: There were a total of 60 patients who were followed up. Three patients in Group II were removed from the analysis as they underwent total knee arthroplasty (TKA). A notably significant improvement was noticed in the ABMDC group on all scores of VAS and MKSSSF with P < 0.0001. The control group continued to be dissatisfied with the treatment they were taking. CONCLUSIONS: This study reveals that a single injection of 5 million of ABMDC was efficient in reducing the symptoms, improving the functional score and betterment of QOL.

Ejemplares similares